Successful clinical applications of IL-1β and TNF-α blockade in RA has led to crucial interest in regulating production of IL-1β and TNF-α and targeting the transcription factors and signaling pathways utilized by IL-1β and TNF-α37. The gene discussed is IL1B; the disease is rheumatoid arthritis.